142 related articles for article (PubMed ID: 2908684)
1. Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease.
Cho WY; Choi HH; Chun HJ; Ahn IM
Korean J Intern Med; 1988 Jan; 3(1):45-51. PubMed ID: 2908684
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of circulating immune complexes in Graves' disease by the Raji cell technique and their relation to different thyroid autoantibodies.
Hopf U; Hütteroth TH; Kotulla P
Horm Metab Res; 1979 Nov; 11(11):622-8. PubMed ID: 231561
[No Abstract] [Full Text] [Related]
3. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
Li J; Gao H; Jin SX
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
[No Abstract] [Full Text] [Related]
5. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.
Akamizu T; Mori T; Imura H; Noh J; Hamada N; Ito K; Koizumi Y; Yamada T; Fujihira T; Eto S
J Endocrinol Invest; 1989; 12(7):483-8. PubMed ID: 2571629
[TBL] [Abstract][Full Text] [Related]
7. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
[TBL] [Abstract][Full Text] [Related]
8. [Method of determining autoantibodies to thyroid antigens in diffuse toxic goiter and Hashimoto's thyroiditis].
Aleksandrova GF; Vnotchenko SL; Konnova EV; Iur'eva NP
Sov Med; 1981; (5):36-9. PubMed ID: 7022680
[No Abstract] [Full Text] [Related]
9. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
10. Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies.
Valente WA; Vitti P; Rotella CM; Vaughan MM; Aloj SM; Grollman EF; Ambesi-Impiombato FS; Kohn LD
N Engl J Med; 1983 Oct; 309(17):1028-34. PubMed ID: 6137770
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to the TSH receptor.
Zakarija M; McKenzie JM
Exp Clin Endocrinol; 1991 May; 97(2-3):165-9. PubMed ID: 1680725
[No Abstract] [Full Text] [Related]
12. Clinical significance of thyrotrophin binding inhibitor immunoglobulins in patients with Graves' disease and various types of thyroiditis.
Lee CS; Kim DM; Kim CS; Yoo HJ
Korean J Intern Med; 1987 Jan; 2(1):112-9. PubMed ID: 2908728
[TBL] [Abstract][Full Text] [Related]
13. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies.
Hidaka A; Kasagi K; Takeuchi R; Iida Y; Misaki T; Grollman EF; Konishi J
Thyroid; 1994; 4(1):31-6. PubMed ID: 7914446
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
15. The pathogenetic connection between Graves' disease and chronic lymphocytic thyroiditis. (The role and incidence of thyroid stimulating antibodies).
Leövey A; Bakó G; Sztojka I; Bordán L; Szabó T; Kálmán K; Balázs C
Acta Med Acad Sci Hung; 1982; 39(1-2):1-6. PubMed ID: 6129766
[TBL] [Abstract][Full Text] [Related]
16. Thyroid disorders in Korean patients with systemic lupus erythematosus.
Park DJ; Cho CS; Lee SH; Park SH; Kim HY
Scand J Rheumatol; 1995; 24(1):13-7. PubMed ID: 7863271
[TBL] [Abstract][Full Text] [Related]
17. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
[TBL] [Abstract][Full Text] [Related]
18. [Study of thyroid autoimmunity in man. Contribution of cell cultures to the study of antibodies stimulating the thyroid gland in Basedow's disease].
Yeni P; Pautard B; Charreire J
Presse Med; 1983 Oct; 12(38):2383-7. PubMed ID: 6314325
[TBL] [Abstract][Full Text] [Related]
19. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
20. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
